A Panel of Angiogenic Factors for Early Bladder Cancer Detection: Enzyme Immunoassay and Western Blot

Journal of Urology

Volumn 181, Issue 3, 2009, Pages 1353-1360

  Eissa, Sanaa ^a   Swellam, Menha ^d   Labib, Randa Ali ^a   El Zayat, Tarek ^c   El Ahmady, Omar ^b  

^a Faculty of Medicine   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Ain Shams University   (Egypt)

^d NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

carcinoma; intercellular signaling peptides and proteins; schistosomiasis; squamous cell; transitional cell; urinary bladder

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; SCATTER FACTOR; VASCULOTROPIN;

ADULT; ARTICLE; BENIGN TUMOR; BLADDER CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MALIGNANT ATROPHIC PAPULOSIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUANTITATIVE DIAGNOSIS; SCHISTOSOMIASIS; SQUAMOUS CELL CARCINOMA; TUMOR VASCULARIZATION; URINALYSIS; URINE CYTOLOGY; WESTERN BLOTTING;

ADULT; ANGIOGENIC PROTEINS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 59349085165     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.102     Document Type: Article

References (17)

1. Poon R.T.P., Fan S.T., and Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19 (2001) 1207
2. Vineis P., Kogevinas M., Simonato L., Brennan P., and Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 463 (2000) 103
3. Shimoyama S., Yamasaki K., Kawahara M., and Kaminishi M. Increased serum angiogenin in colorectal cancer is correlated with cancer progression. Clin Cancer Res 5 (2000) 1125
4. O'Brien T., Smith K., Cranston D., Fuggle S., Bicknell R., and Harris A.L. Urinary basic fibroblast growth factor is elevated in patients with bladder cancer and benign prostatic hypertrophy. Br J Urol 76 (1992) 311
5. Eliot M., Rosen J., Liang A., Yang J., Minh-Hang Y., Chau T., et al. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. J Urol 157 (1997) 72
6. Zhao H., Grossman H.B., Delclos G.L., Hwang L.Y., Troisi C.L., Chamberlain R.M., et al. Increased plasma levels of angiogenin and the risk for bladder carcinoma from: initiation to recurrence. Cancer 104 (2005) 30
7. Murphy W.M., Rivera-Ramirez I., Medina C.A., Wright N.J., and Wajsman Z. The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. J Urol 158 (1997) 2102
8. Cancer Staging Manual. 5th ed. (1997), Lippincott-Raven, Philadelphia 241 American Joint Committee on Cancer (AJCC)
9. Histological Typing of Urinary Bladder Tumors (1973), World Health Organization, Geneva
10. Eissa S., and Seada L. Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin Chem 44 (1998) 1423
11. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248
12. nd ed. (1989), Cold Spring Harbor Press, Cold Spring Harbor 42
13. Eissa S., Kenawy G., Swellam M., Abou El-Fadel A., Abd El-Aal A.A., and El-Ahmady O. Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clin Biochem 37 (2004) 803
14. Sánchez-Carbayo M., Espasa A., Chinchilla V., Herrero E., Megías J., Mira A., et al. New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer. Clin Chem 45 (1999) 1944
15. Rosen E.M., Lamszus K., Laterra J., Polverini P.J., Rubin J.S., and Goldberg I.D. HGF/SF in angiogenesis. Ciba Found Symp 212 (1997) 215
16. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y., and Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor stromal interactions. Cancer Res 57 (1997) 3305
17. Gravas S., Bosinakou I., Kehayas P., and Giannopoulos A. Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential. Urol Int 73 (2004) 173